Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
---|---|---|---|---|---|---|---|---|---|
PRAD | rs112433836 | chr6:43379029 | A/G | 4.11E-12 | 485 | 31.27 | 29.4 | 44.3 | KM Plot |
PRAD | rs11244269 | chr9:133938098 | A/G | 0.000147 | 472 | 32.57 | 30.08 | 29.77 | KM Plot |
PRAD | rs112458858 | chr22:18443009 | GCTAGGCAGTGAGCTCA/G | 3.96E-6 | 494 | 30.8 | 31.87 | 26.37 | KM Plot |
PRAD | rs112539413 | chr1:93859582 | T/TA | 4.51E-6 | 484 | 31.38 | 27.47 | 18.97 | KM Plot |
PRAD | rs112577603 | chr1:202777105 | C/G | 6.88E-6 | 488 | 30.87 | 30.77 | 37.17 | KM Plot |
PRAD | rs112599953 | chr20:2055431 | C/CA | 3.87E-7 | 488 | 28.77 | 33.6 | 29.55 | KM Plot |
PRAD | rs112605315 | chr4:187812160 | C/T | 2.17E-6 | 480 | 31.18 | 28.57 | 26.8 | KM Plot |
PRAD | rs112620640 | chr1:167505230 | A/G | 0.000153 | 486 | 30.77 | 31.25 | 15.77 | KM Plot |
PRAD | rs11263654 | chr11:69238123 | C/T | 1.86E-5 | 494 | 30.97 | 31.13 | 25.5 | KM Plot |
PRAD | rs11263655 | chr11:69238599 | C/G | 1.86E-5 | 494 | 30.97 | 31.13 | 25.5 | KM Plot |
PRAD | rs112678550 | chr1:1158020 | A/C | 3.49E-9 | 490 | 31.27 | 30.73 | 13.73 | KM Plot |
PRAD | rs1126818 | chr17:79617830 | G/A | 2.9E-7 | 472 | 30.78 | 32.4 | 25.67 | KM Plot |
PRAD | rs112690932 | chr4:187811548 | C/G | 2.06E-6 | 483 | 31.13 | 28.57 | 26.8 | KM Plot |
PRAD | rs112691858 | chr20:430132 | G/A | 7.32E-8 | 493 | 31.27 | 24.13 | 21.2 | KM Plot |
PRAD | rs112702671 | chr5:180220930 | C/T | 0 | 485 | 31.13 | 28.1 | 14.87 | KM Plot |